Sio Capital Management, LLC I Mab Transaction History

Sio Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$47.86 - $83.95 $717,900 - $1.26 Million	-15,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.46 - $47.03 $2.84 Million - $4.86 Million	-103,409 Reduced 87.33%	15,000 $705,000
Q2 2020 Aug 14, 2020	SELL	$13.0 - $31.0 $4.61 Million - $11 Million	-354,266 Reduced 74.95%	118,409 $3.54 Million
Q1 2020 May 15, 2020	BUY	$10.63 - $15.37 $5.02 Million - $7.27 Million	472,675 New	472,675 $6.15 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $74.8M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.